Related Experiment Videos
Hemophagocytic Lymphohistiocytosis
Janice Skinner1, Benedicta Yankey1, Brenda K Shelton1
1Janice Skinner is Adult Nurse Practitioner, School of Medicine, Department of Medicine Division of Hematology, Johns Hopkins Bayview Medical Center, Sydney Kimmel Cancer Center, 300 Mason Lord Dr, Baltimore MD 21224 (jskinne2@jhmi.edu). Benedicta Yankey is Nurse Clinician, Sydney Kimmel Cancer Center, Johns Hopkins University, Baltimore, Maryland. Brenda K. Shelton is Clinical Nurse Specialist, Sydney Kimmel Cancer Center, Johns Hopkins University, Baltimore, Maryland.
Early recognition of hemophagocytic lymphohistiocytosis (HLH), a severe hyperinflammatory condition, is critical. Diagnosis involves specific lab findings and imaging, with treatment focused on triggers and immune suppression to improve survival.
Area of Science:
- Hematology
- Immunology
- Critical Care Medicine
Background:
- Hemophagocytic lymphohistiocytosis (HLH) is a rare, life-threatening hyperinflammatory syndrome.
- It leads to multi-organ dysfunction and is associated with high mortality if not promptly diagnosed and treated.
- Varied presentations and limited provider experience pose diagnostic challenges.
Purpose of the Study:
- To summarize the causes, symptoms, diagnostic features, and treatment strategies for HLH.
- To emphasize the critical need for early recognition and intervention in HLH management.
- To highlight advancements in diagnostic and therapeutic approaches for HLH.
Main Methods:
- Review of clinical features, diagnostic criteria, and treatment protocols for HLH.
- Analysis of laboratory and imaging findings indicative of HLH.
- Discussion of therapeutic options including immunosuppression and stem cell transplantation.
Main Results:
- Hallmark findings include fever, cytopenias, coagulopathy, and hepatosplenomegaly.
- Diagnostic markers encompass anemia, thrombocytopenia, elevated ferritin, hypertriglyceridemia, and low NK cell counts.
- Treatment involves addressing triggers, immunosuppression (steroids, etoposide), and potentially stem cell transplantation.
Conclusions:
- Early diagnosis and prompt treatment of HLH are essential for improving patient outcomes.
- While challenging, advancements in diagnostics and therapies have enhanced survival rates for HLH.
- Multidisciplinary care is crucial for managing this complex and severe condition.